Literature DB >> 3413029

Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.

P M Tande1, H Refsum.   

Abstract

The beta-adrenoceptor blocker sotalol has been shown to possess class III antiarrhythmic action. The present study was designed to test the hypothesis that class III antiarrhythmic action and positive inotropy may be linked. Since d,l-sotalol has previously been reported to have variable inotropic effect, we studied direct effects of the d- and l-stereoisomer of sotalol on refractoriness and inotropy of isolated rat atria at different strengths of electrical stimulation. Both the d- and l-stereoisomer of sotalol (7.5 x 10(-5) M) increased the effective refractory period, and to the same extent. However, d-sotalol increased isometric contractile force by 10%, while l-sotalol had no significant effect, when the atria were stimulated at close to threshold values (10 +/- 1 mA). Probably due to release of noradrenaline within the myocardium, contractile force increased when the atria were stimulated at suprathreshold values (40 mA). At suprathreshold stimulation, however, d-sotalol induced a 10% decrease and l-sotalol a 20% decrease, in contractile force. In conclusion, the class III antiarrhythmic action of sotalol is linked with positive inotropy. In the presence of neurotransmitter release, negative inotropic effect of d- and in particular l-sotalol, may occur due to beta-adrenoceptor blocking activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413029     DOI: 10.1111/j.1600-0773.1988.tb01886.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  8 in total

1.  Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.

Authors:  M Sedgwick; H S Rasmussen; D Walker; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

2.  Class III Antiarrhythmics: put to the SWORD?

Authors:  S M Cobbe
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

3.  Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential.

Authors:  Najah Abi-Gerges; Jean-Pierre Valentin; Chris E Pollard
Journal:  Br J Pharmacol       Date:  2009-08-06       Impact factor: 8.739

4.  Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.

Authors:  T Yang; P M Tande; H Refsum
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

5.  Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.

Authors:  H M Hoffmeister; M Beyer; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

6.  Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.

Authors:  K T Koch; D R Düren; P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

Review 7.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 8.  Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.

Authors:  S V Advani; B N Singh
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.